Literature DB >> 1911019

Pharmacokinetics and distribution of ketamine after extradural administration to dogs.

J L Pedraz1, M B Calvo, A R Gascon, R Hernandez, C Muriel, L M Torres, A Dominguez-Gil.   

Abstract

We have studied the pharmacokinetics and distribution of ketamine and its biotransformation products in dogs after extradural administration of ketamine at L4-5. The mean apparent uptake rate constants of ketamine for plasma and CSF were 4.17 (SD 1.84) and 5.15 (2.50) h-1, respectively. The concentrations of ketamine in CSF were greater than those found in plasma. The elimination half-life values of the parent drug for both biological fluids were similar (4.3 (2.96) h and 4.6 (3.31) h for plasma and CSF, respectively). The apparent formation rate constant of norketamine was greater than that of dehydronorketamine. However, the concentrations of the biotransformation products in CSF were smaller than those of the parent drug. These results are similar to the distribution of ketamine and its metabolites in different cerebral structures and tissues. The concentrations decreased in concert with the increase in polarity of the metabolites. A specific distribution for all compounds was observed. Ketamine showed a greater affinity for brainstem, while norketamine and dehydronorketamine were distributed mostly in cerebellum and kidney, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911019     DOI: 10.1093/bja/67.3.310

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  1 in total

1.  Efficacy of Double Drug Impregnated Autologous Coagulum Patch versus Single Drug Impregnated Autologous Coagulum Patch in Postoperative Pain Management after Spinal Surgery.

Authors:  Rabi Narayan Sahu; Jayesh Sardhara; Amit Kumar Singh; Sandeep Sahu; Puja Chovatiya; Arun Kumar Srivastava; Awadhesh Kumar Jaiswal; Anant Mehrotra; Kuntal Kanti Das; Kamlesh Singh Bhaisora; Sanjay Behari
Journal:  Asian J Neurosurg       Date:  2018 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.